{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-129367","form_type":"8-K","ticker":"BNBX","cik":"0000744452","company_name":"BNB PLUS CORP.","filed_at":"2024-12-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.959879+00:00","generated_at":"2026-05-29T02:38:46.212888+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Applied DNA posts FY2024 revenue of $3.4M, net loss $7.1M; announces restructuring and leadership changes","bullets":["Q4 revenue $813K (up vs $780K YoY); FY revenue $3.4M vs $13.4M; net loss Q4 $3.3M ($0.32/sh), FY $7.1M ($1.82/sh).","Pursuing divestiture of CertainT platform; targeting 15% opex reduction vs FY2024, expected by Q2 FY2025.","Judith Murrah promoted to President (salary increased to $400K); Clay Shorrock named President of LineaRx subsidiary.","GMP manufacturing facility buildout to complete by Jan 9, 2025; annual revenue capacity $4M-$16M depending on product mix.","Raised $5.8M net in registered direct offering on Oct 31, 2024; cash ~$10.1M as of Nov 3, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-129367","json":"https://secwatch.observer/filing/0001104659-24-129367.json","markdown":"https://secwatch.observer/filing/0001104659-24-129367.md","text":"https://secwatch.observer/filing/0001104659-24-129367.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/744452/000110465924129367/0001104659-24-129367-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/744452/000110465924129367/tm2431261d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T02:38:46.212888+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}